Epigenomic profiling reveals DNA-methylation changes associated with major psychosis.
Author(s): Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, Bouchard L, Jia P, Assadzadeh A, Flanagan J, Schumacher A, Wang SC, Petronis A
Publication: Am J Hum Genet, 2008, Vol. 82, Page 696-711
PubMed ID: 18319075 PubMed Review Paper? No
Purpose of Paper
Conclusion of Paper
Studies
-
Study Purpose
The purpose of this study was to determine if DNA methylation patterns in brain regions vary as a result of patient gender, postmortem interval, or disease state.
Summary of Findings:
DNA methylation state was not correlated to postmortem interval, brain weight, or brain pH. The extent of CpG island methylation of an area approximately 30 kb upstream of the mitogen-activated protein kinase kinase I (MEK1) gene was significant correlated and inversely proportional to prolonged use of anti-psychotic drugs in biospecimens procured from both male and females diagnosed with schizophrenia but not bipolar disorder. Several sex-specific methylation patterns were also observed.
Biospecimens
Preservative Types
- Frozen
Diagnoses:
- Bipolar Disorder
- Schizophrenia
Platform:
Analyte Technology Platform DNA DNA microarray Pre-analytical Factors:
Classification Pre-analytical Factor Value(s) Preaquisition Patient gender Female
Male
Biospecimen Acquisition Organ measurements Brain weight 1314-1486 g
Preaquisition Diagnosis/ patient condition Bipolar disorder
Schizophrenia
Preaquisition Other drugs Prolonged use of antipsychotic medication (varying doses)